Business / Finance

RSS

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

3 Oct 2019

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

Parafricta to supply all customers directly from 1st October 2016

Frontier Therapeutics Ltd and APA Parafricta Ltd today announced that their exclusive agreement for the distribution of Parafricta® low-friction garments in the UK is to end on September 30th 2016.

From Parafricta 18 Sep 2019

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc., an integrated biopharmaceutical company.

From Tanner Pharma Group 29 Aug 2019

How the FluidFM ADD-ON brings even more “Bio” into BioAFMs

Would you like to unlock unique biological applications for your AFM? Are you interested in single-cell experiments? Then FluidFM might be the right technology to help you with your research.

From Cytosurge AG 28 Aug 2019

Cytosurge AG announces spin-off of its 3D Printing business unit

The 3D Printing business unit of Cytosurge has been recognized as the technological global market leader for additive manufacturing of microscopically small metal components. We are pleased to announce as of today that all 3D Printing activities of Cytosurge will be transitioned into an autonomous entity.

From Cytosurge AG 28 Aug 2019

Medigrowth continues to achieve significant milestones in the Australian cannabis industry

Today, Medigrowth Australia is pleased to provide an update on its activities. Victorian-based Medicinal Cannabis company Medigrowth continues to achieve significant milestones as it navigates a clear path to delivering on its commitment to become a valuable cannabis industry supply chain partner, large scale extraction company and provider of pure, safe and trusted pharmaceutical-grade medical cannabis for delivery to Australian patients.

28 Aug 2019

Enable Injections enters into a development agreement with Genentech

Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

21 Aug 2019

Inciner8 expands its dealer network

Inciner8 are excited to welcome Eco Waste Treatment as a dealer for our customers in Serbia, where we can provide solutions for waste management.

From Inciner8 Limited 16 Aug 2019

Quanterix announces closing of public offering including exercise of underwriters’ option to purchase additional shares

Quanterix announce the closing of its previously announced underwritten public offering of 2,732,673 shares of its common stock.

From Quanterix 13 Aug 2019

Quanterix prices public offering of common stock

Quanterix announce pricing of previously announced underwritten public offering of 2,376,238 shares of common stock public offering price of $25.25 per share.

From Quanterix 9 Aug 2019

Quanterix announces proposed public offering of common stock

Quanterix announced that it has commenced an underwritten public offering of $75 million of shares of its common stock.

From Quanterix 7 Aug 2019

Freiburg start-up company takes over publicly traded company ‘CELLINK AB’

The idea of developing a laboratory instrument that handles and sorts individual, viable cells has been realized by researchers in the Laboratory for MEMS Applications in the Department of Microsystems Engineering at the University of Freiburg.

7 Aug 2019

Quanterix corporation releases operating results for second quarter 2019

Quanterix announced financial results for the three and six months ended June 30, 2019.

From Quanterix 6 Aug 2019

Quanterix to release second quarter 2019 financial results and host conference call on Tuesday, August 6, 2019

Quanterix announced that it will release its financial results for second quarter 2019 before the start of trading on Tuesday, Aug. 6, 2019.

From Quanterix 30 Jul 2019

Inciner8 wins two top accolades for exporting excellence

Southport-based waste management specialist, Inciner8, is celebrating after receiving two top accolades last week, as it was named International Business of the Year by the Echo Regional Business Awards and received a Highly Commended distinction at Insider Media’s Made in the UK Awards national final.

From Inciner8 Limited 8 Jul 2019